Dr Adrian Kilcoyne has left his role as UK medical director at Sanofi Pasteur to join Celgene in the same role.
Taking on his new position this week, Dr Kilcoyne replaces Dr David Gillen who is promoted to head of global drug safety and risk management at Celgene.
He had been UK medical director at Sanofi‘s vaccines business Sanofi Pasteur since 2011, having joined the company from Roche where he was also medical director.
Other former roles include medical director at Baxter Healthcare and senior clinical research physician at Lilly.
This position at Lilly – which he took on in 2006 – was the first step in Dr Kilcoyne’s pharma career and followed several years in primary and secondary care, as well as a spell as a specialist registrar in public health medicines at the Oxford Deanery.
Celgene’s general manager for the UK Sam Pearce said: “He brings with him a wealth of experience that will prove a significant addition to the team, enabling us to continue to build on the already great work we are doing.”